Skip to main content
Terug
DRUG logo

Bright Minds Biosciences Inc.

Datakwaliteit: 83%
DRUG
NASDAQ Healthcare Biotechnology
€ 72,47
▲ € 0,85 (1,19%)
Marktkapitalisatie: 562,48M
Dagbereik
€ 72,47 € 75,70
52-Weeksbereik
€ 23,18 € 123,75
Volume
176.561
50D / 200D Gem.
€ 81,08 / € 58,29
Vorige Slotkoers
€ 71,62

Koershistorie

Financiële Trends

Sectorvergelijking

vs Healthcare sector mediaan (626 peers)

Metriek Aandeel Sector Mediaan
P/E -46,0 0,4
P/B 6,9 2,9
ROE % -27,9 3,7
Net Margin % 3,8
Rev Growth 5Y % 10,0
D/E 0,0 0,2

Belangrijkste Punten

Debt/Equity of 0,00 — conservative balance sheet

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-27,93%
ROIC-12,72%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,00
Current Ratio36,10
Interest Coverage0,00

Waardering

P/E Ratio
-45,99
P/B Ratio6,86
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -12,23M
ROE -27,93% ROA -14,49%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) N/A
ROIC -12,72% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,00 Current Ratio 36,10
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -45,99 P/B Ratio 6,86
P/S Ratio N/A PEG Ratio -0,27
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 562,48M Enterprise Value 479,69M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0,0 0,0 0,0 0,0 0,0
Net Income -12,23M -2,80M -7,37M -14,96M -8,65M
EPS (Diluted) -1,78 -0,65 -1,98 -6,15 -4,74
Gross Profit 0,0 0,0 0,0 0,0 0,0
Operating Income -13,94M -2,82M -7,39M -14,98M -8,62M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 84,42M 6,10M 6,88M 12,09M 20,04M
Total Liabilities 2,38M 568.259,0 280.856,0 1,54M 638.573,0
Shareholders' Equity 82,04M 5,54M 6,60M 10,54M 19,40M
Total Debt 125.777,0 118.960,0 73.549,0 139.911,0 0,0
Cash & Equivalents 82,91M 5,72M 6,75M 11,63M 19,76M
Current Assets 84,31M 5,99M 6,81M 11,95M 20,04M
Current Liabilities 2,34M 528.683,0 280.856,0 1,47M 638.573,0